Ozone Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 9.16 Cr
as on 30-07-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.81 Cr
as on 30-07-2024
- Revenue -4.09%
(FY 2023)
- Profit -85.72%
(FY 2023)
- Ebitda -46.86%
(FY 2023)
- Net Worth 5.09%
(FY 2023)
- Total Assets 5.47%
(FY 2023)
About Ozone Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 9.16 Cr.
The company has closed loans amounting to ₹3.81 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Balija Pavani, Indrasen Kankanala, and Madhusudhn Yeddula serve as directors at the Company.
- CIN/LLPIN
U85100TG2011PTC077803
- Company No.
077803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ozone Institute Of Medical Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balija Pavani  | Director | 29-May-2020 | Current |
| Indrasen Kankanala | Director | 02-Dec-2011 | Current |
| Madhusudhn Yeddula | Director | 22-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Ozone Institute Of Medical Sciences.
Ozone Institute Of Medical Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.09% decrease. The company also saw a substantial fall in profitability, with a 85.72% decrease in profit. The company's net worth moved up by a moderate rise of 5.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ozone Institute Of Medical Sciences?
In 2023, Ozone Institute Of Medical Sciences had a promoter holding of 81.40% and a public holding of 18.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Turbomachinery Engineering Industries Limited
Active 37 years 8 monthsBalija Pavani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Srei Equipment Finance Private Limited Creation Date: 22 Dec 2012 | ₹2.09 Cr | Satisfied |
State Bank Of India Creation Date: 10 Dec 2012 | ₹5.00 M | Satisfied |
Srei Equipment Finance Private Limited Creation Date: 22 Nov 2012 | ₹1.22 Cr | Satisfied |
How Many Employees Work at Ozone Institute Of Medical Sciences?
Ozone Institute Of Medical Sciences has a workforce of 104 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ozone Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ozone Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
